C
C-Lab Ltd
TASE:CLAB
C-Lab Ltd
TASE:CLAB
Price:
1 151
ILS
Market Closed
Market Cap:
₪97.5m
Balance Sheet
Balance Sheet Decomposition
C-Lab Ltd
C-Lab Ltd
Balance Sheet Decomposition is not available for
C-Lab Ltd
C-Lab Ltd
Balance Sheet
C-Lab Ltd
C-Lab Ltd
Currency: ILS
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
3
|
2
|
16
|
8
|
21
|
21
|
20
|
|
| Cash Equivalents |
3
|
2
|
16
|
8
|
21
|
21
|
20
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
14
|
|
| Total Receivables |
19
|
18
|
11
|
13
|
12
|
9
|
6
|
|
| Accounts Receivables |
17
|
16
|
10
|
13
|
12
|
9
|
6
|
|
| Other Receivables |
2
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
28
|
30
|
29
|
47
|
67
|
60
|
49
|
|
| Total Current Assets |
50
|
49
|
55
|
68
|
101
|
91
|
89
|
|
| PP&E Net |
29
|
30
|
26
|
24
|
25
|
24
|
21
|
|
| PP&E Gross |
0
|
0
|
0
|
24
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
32
|
0
|
0
|
0
|
|
| Intangible Assets |
4
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
4
|
2
|
|
| Long-Term Investments |
3
|
3
|
3
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
86
N/A
|
84
-2%
|
85
+1%
|
92
+9%
|
126
+36%
|
119
-5%
|
112
-6%
|
|
| Liabilities | ||||||||
| Accounts Payable |
12
|
13
|
11
|
15
|
19
|
11
|
11
|
|
| Accrued Liabilities |
3
|
3
|
3
|
2
|
3
|
1
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
13
|
11
|
5
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
17
|
14
|
14
|
24
|
39
|
20
|
14
|
|
| Total Current Liabilities |
46
|
41
|
34
|
41
|
61
|
32
|
25
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Other Liabilities |
12
|
12
|
12
|
4
|
4
|
4
|
1
|
|
| Total Liabilities |
58
N/A
|
53
-9%
|
46
-14%
|
45
-1%
|
65
+44%
|
36
-44%
|
26
-27%
|
|
| Equity | ||||||||
| Common Stock |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
65
|
71
|
82
|
83
|
90
|
111
|
114
|
|
| Additional Paid In Capital |
10
|
10
|
10
|
10
|
10
|
10
|
10
|
|
| Treasury Stock |
38
|
38
|
38
|
38
|
38
|
38
|
38
|
|
| Other Equity |
11
|
14
|
16
|
10
|
3
|
2
|
1
|
|
| Total Equity |
27
N/A
|
30
+11%
|
39
+29%
|
47
+20%
|
61
+29%
|
83
+36%
|
86
+4%
|
|
| Total Liabilities & Equity |
86
N/A
|
84
-2%
|
85
+1%
|
92
+9%
|
126
+36%
|
119
-5%
|
112
-6%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
8
|
8
|
8
|
8
|
8
|
8
|
8
|
|
Switch to:
Switch to:
See Also
Discover More
